pcDNA1-Tat Citations (3)

Originally described in: Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping.
Gee P, Lung MSY, Okuzaki Y, Sasakawa N, Iguchi T, Makita Y, Hozumi H, Miura Y, Yang LF, Iwasaki M, Wang XH, Waller MA, Shirai N, Abe YO, Fujita Y, Watanabe K, Kagita A, Iwabuchi KA, Yasuda M, Xu H, Noda T, Komano J, Sakurai H, Inukai N, Hotta A Nat Commun. 2020 Mar 13;11(1):1334. doi: 10.1038/s41467-020-14957-y. PubMed Journal

---

Articles Citing pcDNA1-Tat

Articles
Delivery of engineered extracellular vesicles with miR-29b editing system for muscle atrophy therapy. Chen R, Yuan W, Zheng Y, Zhu X, Jin B, Yang T, Yan Y, Xu W, Chen H, Gao J, Li G, Gokulnath P, Vulugundam G, Li J, Xiao J. J Nanobiotechnology. 2022 Jun 27;20(1):304. doi: 10.1186/s12951-022-01508-4. PubMed
POZ/BTB and AT hook containing zinc finger 1 (PATZ1) suppresses differentiation and regulates metabolism in human embryonic stem cells. Huang M, Liao X, Wang X, Qian Y, Zhang W, Chen G, Wu Q. Int J Biol Sci. 2024 Jan 21;20(4):1142-1159. doi: 10.7150/ijbs.83927. eCollection 2024. PubMed
Transcriptomic Analysis Reveals Key Pathways Influenced by HIV-2 Vpx. Szojka ZI, Kunkli B, Kiarie IW, Linkner TR, Al-Muffti AS, Ahmad H, Benko S, Jansson M, Tozser J, Mahdi M. Int J Mol Sci. 2025 Apr 8;26(8):3460. doi: 10.3390/ijms26083460. PubMed

If you have published an article using this material, please email us at to have your article added to this page.